Walleye Capital’s Harte-Hanks HHS Stock Holding History

Walleye Capital’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,391	Closed	-$149K	–	3372
2022 Q3	$149K	Buy	+13,391	New	+$179K	﹤0.01%	2256

Other funds holding HHS

WCM

Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Walleye Capital's HHS Position: Q4 2022 in Review

Walleye Capital sold out of Harte-Hanks (HHS) in Q4 2022, closing a stake of 13,391 shares — an estimated $149K sold.

Walleye Capital first reported a position in HHS in Q3 2022 and held it in 1 quarter. The position peaked at $149K in Q3 2022. 40 funds tracked by Wall St. Rank hold HHS as of Q4 2022.

Walleye Capital reported no remaining Harte-Hanks position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 13,391 Harte-Hanks shares in Q4 2022, an estimated $149K.
Walleye Capital first reported a position in Harte-Hanks in Q3 2022 and held it in 1 quarter.
Walleye Capital's Harte-Hanks position peaked at $149K in Q3 2022.
40 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.